Atrial Fibrillation (AF) Clinical Trials in Wuhan, Hubei
5 recruitingWuhan, Hubei, China
Showing 1–5 of 5 trials
Recruiting
Not Applicable
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
Sleep-disordered breathing (SDB)Obstructive Sleep ApneaArrhythmia+3 more
Beijing Anzhen Hospital658 enrolled27 locationsNCT07444372
Recruiting
Early Phase 1
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases3,160 enrolled12 locationsNCT06615596
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled734 locationsNCT05712200
Recruiting
Not Applicable
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
Atrial Fibrillation (AF)Catheter AblationAtrial Functional Mitral Regurgitation
Beijing Anzhen Hospital146 enrolled17 locationsNCT06883864
Recruiting
Not Applicable
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
Atrial Fibrillation (AF)
Beijing Anzhen Hospital4,100 enrolled22 locationsNCT06871228